Bavarian Nordic to Host Third Quarter 2023 Results Conference Call and Webcast
The management of Bavarian Nordic will host a conference call at 2:00 pm CET (8:00 am EST) on the same day to present the interim results followed by a Q&A session. A listen-only version of the call and presentation slides can be accessed via https://bit.ly/3tonMNp. To join the Q&A session, please register in advance via https://bit.ly/48Cp0F2.
Bavarian Nordic is a fully integrated vaccine company focused on the research and development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.
Bavarian Nordic GmbH
Fraunhoferstrasse 13
82152 Martinsried
Telefon: +49 (89) 255446300
Telefax: +49 (89) 255446333
http://www.bavarian-nordic.com
Vice President Investor Relations
Telefon: +45 (61) 7747-43
Das könnte dich ebenfalls interessieren
AngaCom (Messe | Köln)
Franz Vallée auf der World Conference on Transport Research in Montreal
